Kaori Kondo

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Clinical outcomes of idecabtagene vicleucel therapy for relapsed/refractory multiple myeloma: a single-center retrospective analysis

Clinical outcomes of idecabtagene vicleucel therapy for relapsed/refractory multiple myeloma: a single-center retrospective analysis

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: May 13, 2026

Clinical impact of pre-transplant estimated glomerular filtration rate using the CKD-EPI equation with serum creatinine on outcomes after single-unit cord blood transplantation in adults.

Clinical impact of pre-transplant estimated glomerular filtration rate using the CKD-EPI equation with serum creatinine on outcomes after single-unit cord blood transplantation in adults.

Journal: Leukemia & lymphoma

Published: April 10, 2026

Case Report: Immune-driven clonal selection underlying lineage switch from B-Precursor acute lymphoblastic leukemia to acute myeloid leukemia following inotuzumab ozogamicin.

Case Report: Immune-driven clonal selection underlying lineage switch from B-Precursor acute lymphoblastic leukemia to acute myeloid leukemia following inotuzumab ozogamicin.

Journal: Frontiers in immunology

Published: March 12, 2026

Changes in Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for FLT3-ITD-mutated Acute Myeloid Leukemia in the FLT3 Inhibitor Era.

Changes in Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for FLT3-ITD-mutated Acute Myeloid Leukemia in the FLT3 Inhibitor Era.

Journal: Clinical lymphoma, myeloma & leukemia

Published: February 08, 2026

Recipient polymorphism of the C-reactive protein (CRP) gene rs2794521 stratified disease-free survival, but did not influence maximum serum CRP levels during neutropenia after single-unit cord blood transplantation in adults.

Recipient polymorphism of the C-reactive protein (CRP) gene rs2794521 stratified disease-free survival, but did not influence maximum serum CRP levels during neutropenia after single-unit cord blood transplantation in adults.

Journal: Leukemia & lymphoma

Published: December 04, 2025

Comparative analysis of the acute myeloid leukemia-composite model and treatment-related mortality score in single-unit cord blood transplantation.

Comparative analysis of the acute myeloid leukemia-composite model and treatment-related mortality score in single-unit cord blood transplantation.

Journal: Leukemia & lymphoma

Published: October 31, 2025

Elevation of White Blood Cell Count After G-CSF-Combined Conditioning Predicts Relapse and Disease-Free Survival Following Single-Unit Cord Blood Transplantation for Myeloid Malignancies.

Elevation of White Blood Cell Count After G-CSF-Combined Conditioning Predicts Relapse and Disease-Free Survival Following Single-Unit Cord Blood Transplantation for Myeloid Malignancies.

Journal: Transplantation and cellular therapy

Published: September 08, 2025

Effectiveness and safety of ibrutinib for steroid-dependent/refractory chronic graft-versus-host disease: a single-center analysis

Effectiveness and safety of ibrutinib for steroid-dependent/refractory chronic graft-versus-host disease: a single-center analysis

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: September 03, 2025

Toll-Like Receptor Polymorphisms Influence Graft-Versus-Host Disease and Infection Risk After Single-Unit Cord Blood Transplantation for Adults.

Toll-Like Receptor Polymorphisms Influence Graft-Versus-Host Disease and Infection Risk After Single-Unit Cord Blood Transplantation for Adults.

Journal: European journal of haematology

Published: August 12, 2025

Ponatinib/blinatumomab for relapsed Philadelphia chromosome-positive leukemia as a bridge to allogeneic transplantation.

Ponatinib/blinatumomab for relapsed Philadelphia chromosome-positive leukemia as a bridge to allogeneic transplantation.

Journal: Hematology (Amsterdam, Netherlands)

Published: July 29, 2025

HCT-VTE-J Model to Predict Late-Onset Venous Thromboembolism after Allogeneic Hematopoietic Stem Cell Transplantation: A Japanese Single-Center Study.

HCT-VTE-J Model to Predict Late-Onset Venous Thromboembolism after Allogeneic Hematopoietic Stem Cell Transplantation: A Japanese Single-Center Study.

Journal: Transplantation and cellular therapy

Published: July 08, 2025

Real-World Efficacy of Extending Duration of Letermovir Prophylaxis for Allogeneic Stem Cell Recipients.

Real-World Efficacy of Extending Duration of Letermovir Prophylaxis for Allogeneic Stem Cell Recipients.

Journal: Transplant infectious disease : an official journal of the Transplantation Society

Published: March 10, 2025

Showing 1-12 of 27

Last Updated: 09/26/2026